Using the Morisky Scale as a screening tool for life insurance policies can benefit both the insurer and the policyholder. Here are some ways:
0 Comments
As healthcare costs continue to rise, employers are seeking ways to minimize expenses without sacrificing the quality of care their employees receive. One effective approach is to focus on medication adherence through programs like the Morisky Medication Adherence Scale (MMAS).
Medication non-adherence is a significant problem that can result in increased healthcare utilization, hospitalizations, and healthcare costs. According to a report from the National Council on Patient Information and Education, medication non-adherence costs the US healthcare system between $100 and $300 billion annually. The MMAS is a tool that assesses medication adherence based on a set of questions that ask patients about their medication-taking behavior. It has been used in various settings, including employer health plans, to identify patients who may need additional support to adhere to their medications. Employers can implement the MMAS as part of their employee health plan by partnering with a third-party vendor or working with their health plan provider. The program typically involves outreach to employees who have been identified as non-adherent to their medications through the MMAS questionnaire. The outreach may include education about the importance of medication adherence, reminders to take medications, and access to resources such as pharmacy support. By improving medication adherence, employers can potentially reduce healthcare costs and premiums. A study published in the Journal of Occupational and Environmental Medicine found that an intervention to improve medication adherence in employees with hypertension resulted in a significant reduction in healthcare costs and an increase in productivity. Additionally, medication adherence programs can improve employee health outcomes and reduce the need for costly medical interventions. For example, employees with diabetes who adhere to their medications are less likely to require hospitalization or emergency department visits, which can result in significant cost savings. In conclusion, implementing medication adherence programs like the MMAS can be an effective way for employers to minimize healthcare costs and premiums. By identifying and supporting employees who struggle with medication adherence, employers can improve health outcomes, reduce healthcare utilization, and ultimately save money. Investing in employee health and well-being is a win-win for both employers and employees. Permission from Dr. Morisky is required to use the copyrighted Morisky Scales (MMAS-4 and MMAS-8), the most commonly used validated measure of medication non-adherence. The MMAS Scales are not subject to fair use, as we have had the unfortunate circumstance to litigate against large pharma and prestigious universities in order to protect our intellectual property. Although the settlements are private, public records will show whom we've had to force to comply.
external links with excellent resources to enhance medication adherence efforts:
American Society on Aging/American Society of Consultant Pharmacists Foundation Adult Meducation Set New York City Medication Adherence Project In 2015, Medicare began offering monthly reimbursements for chronic care management (CCM). Use of the Morisky Scale for CCM services are billed under CPT 99490 for chronically ill Medicare patients and include at least 20 minutes of non-face to face time directed by a physician or other qualified health care professional, per calendar month. Consent must be documented in the patients medical record. A HUGE ADVANTAGE for using the Morisky Scales is they are validated with an Internal Consistency Cronbach's alpha .83, Sensitivity 93%, and Specificity 57%.
Congratulations Dr. Morisky for being recognized by the Marquis Who’s Who Top Professionals as having achieved a high level of recognition and achievement in the public health profession.
Philip Morisky, CEO of MMAR, provides an overview of using the MMAS-4 as a screening tool to assess medication non-adherence as part of standard care for a group of pharmacists and students at AUHS.
The MMAS-4 is a highly validated scale that can quickly assess a patient’s medication taking behavior. For patients found to be non-adherent the MMAS-8 scale is not only used for measuring the magnitude of non-adherence but also provides a diagnostic assessment as to why the patient is non-adherent so health care providers can tailor educational counseling sessions and motivational interviewing questions to improve their medication taking behavior. Today the MGL scale I published in Medical Care in 1986 has been cited over 7000 times in medical journals. In a large-scale randomized clinical trial, I compared patients who received an educational intervention and educational consultation to patients in a standard care group. 5-year study outcomes identified significant positive differences in patient knowledge of the medical regimen, higher levels of adherence behavior, and reduced levels of morbidity and mortality.
Donald E. Morisky's research while affiliated with County of Los Angeles Public Health and other places
https://www.researchgate.net/scientific-contributions/Donald-E-Morisky-2141976607 |
AuthorDr Donald Morisky. Archives
November 2023
Categories |